Systemic Inflammation Response Index (SIRI): The Three-Cell Read on Chronic Inflammation

The SIRI score, defined in plain terms

The Systemic Inflammation Response Index (SIRI) is a composite biomarker calculated from three white blood cell types — neutrophils, monocytes, and lymphocytes — available from a routine complete blood count (CBC). By multiplying the two pro-inflammatory cell types in the numerator and dividing by the immune-regulatory cell type in the denominator, SIRI distills the balance between inflammatory drive and immune regulation into a single, trackable number. A higher SIRI suggests inflammatory activity is outpacing regulatory capacity; a lower SIRI reflects a calmer, better-balanced immune state.

SIRI is sometimes confused with the Systemic Immune-Inflammation Index (SII), which uses platelets instead of monocytes: SII = (Platelets × Neutrophils) ÷ Lymphocytes. Because monocytes — not platelets — are central drivers of chronic, tissue-level inflammation, SIRI may be especially relevant for tracking the sustained, low-grade inflammation that underlies cardiovascular disease, metabolic dysfunction, and aging. The Neutrophil-to-Lymphocyte Ratio (NLR), another commonly measured index, uses only two cell types and therefore captures a narrower picture of immune activity.

Why monocytes are the cell SIRI watches

Your immune system operates as a carefully calibrated seesaw. On one side, neutrophils and monocytes drive inflammation — they rush to sites of injury, engulf pathogens, and release cytokines that recruit additional immune cells. On the other side, lymphocytes act as regulators and strategists, coordinating targeted responses, producing antibodies, and helping resolve inflammation once the job is done. SIRI quantifies this balance. When neutrophils and monocytes are elevated relative to lymphocytes, the body is spending more resources on inflammatory activity and less on immune regulation — a pattern researchers have linked to accelerated aging, cardiovascular disease, and metabolic dysfunction.

What makes monocytes the load-bearing component that distinguishes SIRI from NLR and SII is their dual tissue role. NLR captures only the neutrophil-to-lymphocyte axis — a useful signal for acute stress and infection, but one that misses the chronic, tissue-infiltrating arm of inflammation entirely. SII substitutes platelets, which reflect clotting and vascular activation but not the cellular infiltration of arterial walls. Monocytes fill that gap. In the bloodstream, monocytes are relatively quiescent. But when they enter tissues, they transform into macrophages that can either promote inflammation (M1 macrophages) or support tissue repair (M2 macrophages). Chronically elevated monocytes suggest that the body is continuously sending inflammatory reinforcements into tissues — a hallmark of conditions like atherosclerosis. By including monocytes in the numerator alongside neutrophils, SIRI captures this chronic, tissue-level inflammatory infiltration that neither NLR nor SII can see.

The SIRI formula, worked through with real values

SIRI = (Neutrophil count × Monocyte count) ÷ Lymphocyte count

All three values are absolute counts from a standard CBC with differential, expressed in cells × 10⁹/L. The result is dimensionless. SIRI was developed by Qi and colleagues in 2016 for oncology research and has since been validated across population-level cardiovascular and metabolic studies. It is not automatically reported by most laboratories — calculate it from the raw differential counts on your CBC report.

No fasting is required; standard venipuncture is sufficient. For serial comparisons, drawing at the same time of day is recommended to minimize circadian variation in neutrophil counts.

Worked example

• Neutrophil count: 4.0 × 10⁹/L
• Monocyte count: 0.6 × 10⁹/L
• Lymphocyte count: 1.9 × 10⁹/L

SIRI = (4.0 × 0.6) ÷ 1.9 = 2.4 ÷ 1.9 = 1.26

A value of 1.26 falls in the transitional zone (1.0–1.5), reflecting mild subclinical pro-inflammatory activity that warrants serial monitoring.

Where your SIRI score lands on published gradients

A landmark 20-year cohort study of 42,875 U.S. adults published in the Journal of Clinical Medicine (2023) stratified SIRI into quartiles based on observed mortality outcomes. These are research-derived quartiles, not universally standardized clinical cutoffs — no such cutoffs currently exist for SIRI.

NHANES research quartiles

• Q1 — SIRI below 0.68: associated with the lowest risk of all-cause and cardiovascular mortality
• Q2 — SIRI 0.68 to 0.98: intermediate-low risk range
• Q3 — SIRI 0.99 to 1.42: intermediate-high risk range
• Q4 — SIRI above 1.43: associated with significantly elevated mortality risk

General interpretive framework

• Below 0.5: suggests minimal systemic inflammation and a well-regulated immune response
• 0.5 to 1.0: generally considered a favorable range for most healthy adults
• 1.0 to 1.5: a transitional zone that may reflect mild, subclinical inflammation
• Above 1.5: signals that pro-inflammatory activity is outpacing immune regulation; consistently associated with higher risk across multiple large studies

A single SIRI measurement is most useful when interpreted alongside other biomarkers and overall health context. A very low SIRI driven by unusually low neutrophil or monocyte counts could reflect immunosuppression rather than optimal immune balance and warrants clinical evaluation. Trending SIRI over multiple measurements provides a far more reliable picture than any single snapshot.

Factors that move the SIRI score

Dietary fat quality

A population-based analysis found that higher dietary omega-3 fatty acid intake is inversely associated with SIRI levels. Research associates anti-inflammatory dietary patterns — including fatty fish, leafy greens, berries, nuts, seeds, and extra-virgin olive oil — with lower SIRI over time, while diets high in refined starches, added sugars, and ultra-processed foods are associated with higher values. Omega-3 fatty acids (EPA and DHA) appear to modulate neutrophil activation, which directly affects the numerator of the SIRI calculation.

Physical activity

Sedentary behavior is associated with higher median SIRI values compared to more active counterparts. Regular moderate exercise is associated with a shift in the balance between innate immune activation (neutrophils, monocytes) and adaptive immune regulation (lymphocytes). Chronic overtraining without adequate recovery is associated with transient spikes in SIRI, reflecting the acute inflammatory load of tissue damage.

Sleep and psychological stress

Inadequate sleep is associated with elevated neutrophil and monocyte activity while suppressing lymphocyte function — a combination that raises SIRI through both the numerator and denominator simultaneously. Chronic psychological stress drives a similar cortisol-mediated immune shift, redistributing white blood cell populations toward a more pro-inflammatory profile.

Visceral adiposity

Excess visceral adipose tissue is a source of pro-inflammatory cytokines associated with elevated SIRI. Studies consistently show that obesity is positively associated with higher SIRI values, and that this relationship is driven in part by the chronic monocyte and neutrophil activation that visceral fat depots sustain.

Underlying medical conditions

Secondary drivers — including autoimmune disorders, chronic infections, sleep apnea, and metabolic disease — sustain neutrophil and monocyte activation independently of lifestyle factors. Persistently elevated SIRI in the context of otherwise stable lifestyle variables may reflect one of these underlying conditions as the primary source of immune imbalance.

Supplements

Omega-3 fatty acids (EPA and DHA) are directly linked to lower SIRI in population studies. Vitamin D plays a role in immune regulation, and curcumin has demonstrated anti-inflammatory properties in clinical trials. The magnitude of these associations varies across individuals and study populations.

Markers that read SIRI alongside chronic inflammation

• Neutrophils — the first numerator input; rising neutrophil count drives SIRI up independently of monocyte or lymphocyte shifts and is the most common acute-illness confounder.
• Monocytes — the second numerator input; the component that makes SIRI distinct from NLR; elevated monocytes signal chronic tissue-level inflammatory infiltration (atherosclerosis, metabolic disease) that NLR misses.
• Lymphocytes — the denominator and adaptive immune counterweight; falling lymphocyte count (viral infection, chronic stress) elevates SIRI even when innate cells are stable.
• Neutrophil-to-lymphocyte ratio (NLR) — the two-cell predecessor to SIRI; comparing NLR with SIRI on the same draw shows how much of the inflammatory signal is monocyte-driven vs. neutrophil-driven.
• High-sensitivity C-reactive protein (hs-CRP) — confirms whether the cellular immune imbalance is generating a downstream acute-phase response; hs-CRP captures the systemic consequence, SIRI captures the upstream cellular driver.
• Erythrocyte sedimentation rate (ESR) — a second downstream inflammation marker; comparing ESR with SIRI clarifies whether the inflammatory signal is acute (high ESR + high SIRI) or predominantly cellular/chronic (high SIRI + normal ESR).
• Systemic Immune-Inflammation Index (SII) — uses platelets instead of monocytes; comparing SII with SIRI on the same draw helps distinguish platelet-driven vascular activation from monocyte-driven tissue infiltration.

A realistic retest cadence for the SIRI score

SIRI components — neutrophils, monocytes, and lymphocytes — are rapid-turnover cells with day-to-week response times, making SIRI one of the more responsive composite inflammation markers available from a standard CBC. A 4–8 week retest interval is appropriate for capturing meaningful lifestyle-driven changes.

Single values are inherently noisy. Acute infection, intense exercise, or vaccination in the days before a draw will transiently spike neutrophil and monocyte counts, elevating SIRI independently of any underlying trend. Confirm directional shifts across 2–3 serial measurements before interpreting a change as meaningful. For comparable serial values, draw at the same laboratory, at the same time of day, in a resting state, and with no acute illness in the preceding week.

For stable individuals monitoring systemic inflammatory baseline without an active clinical concern, tracking SIRI quarterly or every 6 months is appropriate. More frequent monitoring may be warranted when an underlying condition is being managed or when a significant lifestyle intervention has been introduced.

When SIRI findings deserve a clinician conversation

Chronic inflammation rarely announces itself with obvious symptoms in its early stages. SIRI offers a way to detect these shifts early — before they cross the threshold into disease — using data already available from a standard blood draw.

The long-term outcome data from population research underscores when clinical follow-up is warranted. A 20-year NHANES cohort study found that adults with the highest SIRI values had significantly higher risk of both cardiovascular and all-cause mortality. In patients with hypertension, elevated SIRI is independently associated with increased mortality. For every one-unit increase in SIRI, the risk of developing heart failure rises by approximately 20%. In a study of over 40,000 U.S. adults, the highest SIRI levels were associated with a 79% increased incidence of chronic kidney disease. Emerging research also demonstrates that higher SIRI levels are associated with lower scores on cognitive performance tests.

A clinician conversation is appropriate when: SIRI is persistently above 1.5 across two or more serial measurements; SIRI is trending upward without an identifiable transient cause (recent infection, vaccination, intense training); SIRI is elevated alongside other markers of cardiovascular, metabolic, or renal risk; or SIRI is unusually low in a way that may reflect immunosuppression rather than optimal immune balance.

Superpower includes SIRI as part of a comprehensive biomarker panel that measures over 100 markers in a single blood draw — including all CBC components needed to calculate SIRI, along with hs-CRP, ESR, ferritin, and metabolic and hormonal biomarkers. Results come with access to Superpower's care team, who can help interpret SIRI in the context of a complete biomarker profile. Learn more about the approach at our manifesto.